Léčiva ovlivňující motorický systém Antiparkinsonika
Transkript
Léčiva ovlivňující motorický systém Antiparkinsonika
Antiemetics & Prokinetics Jan Strojil Ústav farmakologie LF UP October 17, 2006 Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Outline n Introduction ‐ physiology o Antidopaminergic p Antihistaminic q Anti 5‐HT3 r Antimuscarinic s Other, Prokinetics & Emetics Jan Strojil Antiemetics & Prokinetics Other Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other Physiology Úvod Vomiting: forceful expulsion of the contents of oneʹs stomach through the mouth (wikipedia.org) • good poison ingestion gastric irritation • bad kinetosis gravidity chemotherapy (or other drugs) intracranial processes (↑ pressure) vestibular disorders Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Physiology Úvod Consequences of repeated vomiting • hypochloremic metabolic alkalosis • secondary hypokalemia (kidneys) • teeth damage • aspiration Jan Strojil Antiemetics & Prokinetics Other Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other Physiology Úvod Stimulus Pain, repulsive sights and smells, emotions Input Sensory afferents and CNS pathways H1 and M blockers Motion sickness Integration Output Higher centers Dopamine antagonists, 5-HT3 blockers Labyrinth Vestibular nuclei (H1 and mACh R) CTZ (D2 and 5-HT3 R) Vomiting centre (mACh R) Nerves to visceral and somatic receptors Blood Endogenous toxins, drugs Release of emetogenic agents (5-HT, prostanoids, free radicals) Stimuli from pharynx and stomach M blockers Nucleus tractus solitarii (mACh and H1 R) Visceral afferents (5-HT3 R?) H1 blockers 5-HT3 blockers Rang, Ritter, Dale & Moore, Pharmacology, 2003 Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Antidopaminergic n Introduction ‐ physiology o Antidopaminergic p Antihistaminic q Anti 5‐HT3 r Antimuscarinic s Other, Prokinetics & Emetics Jan Strojil Antiemetics & Prokinetics Other Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other Physiology Úvod Stimulus Pain, repulsive sights and smells, emotions Input Sensory afferents and CNS pathways H1 and M blockers Motion sickness Integration Output Higher centers Dopamine antagonists, 5-HT3 blockers Labyrinth Vestibular nuclei (H1 and mACh R) CTZ (D2 and 5-HT3 R) Vomiting centre (mACh R) Nerves to visceral and somatic receptors Blood Endogenous toxins, drugs Release of emetogenic agents (5-HT, prostanoids, free radicals) Stimuli from pharynx and stomach M blockers Nucleus tractus solitarii (mACh and H1 R) Visceral afferents (5-HT3 R?) H1 blockers 5-HT3 blockers Rang, Ritter, Dale & Moore, Pharmacology, 2003 Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Antidopaminergic ‐ D2 receptor blockers Úvod • mechanisms of action – block transmission in CTZ – cancel dopamine inhibition of the stomach – in high doses also 5‐HT3 • indications – PONV – drug induced N/V – migraine – gastric paresis in DM – before GI radiology (prokinetic) Jan Strojil Antiemetics & Prokinetics Other Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Antidopaminergic ‐ side effects Úvod • side effects – extrapyramidal – ↑ prolactin – malign neuroleptic syndrome – dizziness • contraindications – prolactinoma – Parkinson’s • interactions – can improve absorption Jan Strojil Antiemetics & Prokinetics Other Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Antidopaminergic ‐ drugs Úvod • metoclopramide (Reglan ® [USA], Maxolon® [UK]) – 10‐20 mg p.o., i.m., i.v. – crosses BBB • itopride (Ganaton ® [D], Itax® [USA]) – also some i‐ACHE activity – better prokinetic • cisapride (Propulsid ) ® – QT prolongation – discontinued • alizapride, domperidone (Motilium ) ® – do not cross BBB Jan Strojil Antiemetics & Prokinetics Other Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Antidopaminergic ‐ drugs Úvod • antipsychotics – chlorpromazine – methotrimeprazine – perphenazine – prochlorperazine – trifluoperazine – triflupromazine Jan Strojil Antiemetics & Prokinetics Other Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Antihistamines n Introduction ‐ physiology o Antidopaminergic p Antihistaminic q Anti 5‐HT3 r Antimuscarinic s Other, Prokinetics & Emetics Jan Strojil Antiemetics & Prokinetics Other Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other Antihistaminic ‐ physiology Úvod Stimulus Pain, repulsive sights and smells, emotions Input Sensory afferents and CNS pathways H1 and M blockers Motion sickness Integration Output Higher centers Dopamine antagonists, 5-HT3 blockers Labyrinth Vestibular nuclei (H1 and mACh R) CTZ (D2 and 5-HT3 R) Vomiting centre (mACh R) Nerves to visceral and somatic receptors Blood Endogenous toxins, drugs Release of emetogenic agents (5-HT, prostanoids, free radicals) Stimuli from pharynx and stomach M blockers Nucleus tractus solitarii (mACh and H1 R) Visceral afferents (5-HT3 R?) H1 blockers 5-HT3 blockers Rang, Ritter, Dale & Moore, Pharmacology, 2003 Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Antihistaminic ‐ H1 receptor blockers Úvod • mechanisms of action – block vestibular and visceral system – also sedative action – many have anti M as well • indications – kinetosis (motion or sea sickness) – gravidity – Meniér‘s disease Jan Strojil Antiemetics & Prokinetics Other Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Antihistaminic ‐ side effects Úvod • side effects – sedation – can mask symptoms of aminoglycoside damage – parasympatolytic – dizziness • contraindications – asthma – ileus • interactions – i‐MAOs Jan Strojil Antiemetics & Prokinetics Other Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Antihistaminic ‐ drugs Úvod • dimenhydrinate (Travel‐Gum ) ® – unsuitable for drivers • embramine (Medrin) – vertigo – Meniér‘s • meclozine (meclizine) (Antivert , Bonine ) ® ® – same as dimenhydrinate Jan Strojil Antiemetics & Prokinetics Other Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other Anti 5‐HT3 n Introduction ‐ physiology o Antidopaminergic p Antihistaminic q Anti 5‐HT3 r Antimuscarinic s Other, Prokinetics & Emetics Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other Anti 5‐HT Úvod 3 ‐ physiology Stimulus Pain, repulsive sights and smells, emotions Input Sensory afferents and CNS pathways H1 and M blockers Motion sickness Integration Output Higher centers Dopamine antagonists, 5-HT3 blockers Labyrinth Vestibular nuclei (H1 and mACh R) CTZ (D2 and 5-HT3 R) Vomiting centre (mACh R) Nerves to visceral and somatic receptors Blood Endogenous toxins, drugs Release of emetogenic agents (5-HT, prostanoids, free radicals) Stimuli from pharynx and stomach M blockers Nucleus tractus solitarii (mACh and H1 R) Visceral afferents (5-HT3 R?) H1 blockers 5-HT3 blockers Rang, Ritter, Dale & Moore, Pharmacology, 2003 Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other 5‐HT Úvod3 receptor blockers • mechanisms of action – serotonine block (mainly in CTZ) – very effective • indications – chemotherapy N/V (cis‐platine) – postradiotherapy N/V – PONV – most other causes Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other 5‐HT Úvod3 receptor blockers ‐ side effects • side effects – usually mild – obstipation • contraindications – no info on children and pregnant women • interactions – none known Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other 5‐HT Úvod3 receptor blockers ‐ drugs • ondansetron (Zofran , Ondemet ) ® ® – a breaktrough in chemotherapy – short T½ (3 hours) • tropisetron, dolasetron – longer T½ • palosetron, granisetron – parenteral application • beneficial combination with dexamethasone • alosetron used in IBS Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Antimuscarinic n Introduction ‐ physiology o Antidopaminergic p Antihistaminic q Anti 5‐HT3 r Antimuscarinic s Other, Prokinetics & Emetics Jan Strojil Antiemetics & Prokinetics Other Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other Antimuscarinic ‐ physiology Úvod Stimulus Pain, repulsive sights and smells, emotions Input Sensory afferents and CNS pathways H1 and M blockers Motion sickness Integration Output Higher centers Dopamine antagonists, 5-HT3 blockers Labyrinth Vestibular nuclei (H1 and mACh R) CTZ (D2 and 5-HT3 R) Vomiting centre (mACh R) Nerves to visceral and somatic receptors Blood Endogenous toxins, drugs Release of emetogenic agents (5-HT, prostanoids, free radicals) Stimuli from pharynx and stomach M blockers Nucleus tractus solitarii (mACh and H1 R) Visceral afferents (5-HT3 R?) H1 blockers 5-HT3 blockers Rang, Ritter, Dale & Moore, Pharmacology, 2003 Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other Antimuscarinic Úvod • mechanisms of action – M receptor block – mainly vestibular • indications – kinetosis Brugmansia x insignis Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Antimuscarinic ‐ side effects Úvod • side effects – sedation – parasympatolytic • contraindications – glaucoma • MKULTRA project Jan Strojil Antiemetics & Prokinetics Other Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Antimuscarinic ‐ drugs Úvod • skopolamin (hyoscine) – maily for kinetosis – several mg per os – today in the form of TTS (0,5 mg) Jan Strojil Antiemetics & Prokinetics Other Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other Antimuscarinic n Introduction ‐ physiology o Antidopaminergic p Antihistaminic q Anti 5‐HT3 r Antimuscarinic s Other, Prokinetics & Emetics Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other Other Úvod • NK‐1 receptor blockers – aprepitant – central action – in combination with 5‐HT3 and dexamethasone • steroids – dexamethasone • BDZ – • magnesium Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other Prokinetics ‐ summary Úvod • D2 blockers – e.g. metoclopramide, itopride – GERD, diabetic gastroparesis, radiology • iACHE – stigmines • motilin – natural substance (erythromycin) Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other Emetics Úvod • Tinctura ipecacuanhae – strong emetic – deprecated – only certain indications – not as effective as lavage • emetics in small doses – expectorans Jan Strojil Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other Úvod Family Guy, © Fox Network Antiemetics & Prokinetics Intro Antidopaminergic Antihistaminic Anti 5‐HT3 Antimuscarinic Other Úvod Thank you for your attention Jan Strojil Antiemetics & Prokinetics
Podobné dokumenty
Sledování výSkytu polárních kontaminantů ve vybraných profilech
Autor: Mgr. Roman Grabic, Ph.D., doc. Ing. Tomáš Randák, Ph.D., doc. Ing. Vladimír Žlábek Ph.D., Ing. Jan Turek,
Ph.D., Ganna Fedorova M.Sc.
Jihočeská univerzita v Českých Budějovicích, Faku...
Refluxní choroba jícnu
choroba jícnu. Standardy České gastroenterologické
společnosti – aktualizace 2009. Vnitř Lék 2009;
Extraezofageální refluxní choroba
Extraezofageální reflux (EER) je stav, kdy dochází k průniku (duodeno)gastrického obsahu nad úroveň horního jícnového svěrače (HJS).
ADRESA PRO KORESPONDENCI:
MUDr. Karel Lukáš, CSc.
IV. interní kl...